Go back to Newsroom

Emmes Appoints Matt Bond as CFO

Go back to Newsroom

Go back to Newsroom

US-Based Emmes Acquires VaxTRIALS

Go back to Newsroom

Go back to Newsroom

Emmes announces reorganization and launch of AI unit

Go back to Newsroom

Go back to Newsroom

Psychedelic Therapy Faces Regulatory Hurdles Despite Promising Research

Go back to Newsroom

Go back to Newsroom

A CRO Should be the Partner that Gives Full Visibility on a Gene Therapy Trials Path

Go back to Newsroom

Go back to Newsroom

Essex Management Appoints David Loose as Chief Executive Officer Appointment Reflects Commitment to Continuing Essex’s Strategic Vision ROCKVILLE, MD

Go back to Newsroom

Go back to Newsroom

SCOPE Summit 2025: Emmes' Peter Ronco on Small Biopharma & Clinical Trial Partnerships

Go back to Newsroom

Go back to Newsroom

Large Language Models and Beyond: AI’s Impact on Clinical Trial Efficiency and Integrity

Go back to Newsroom

Go back to Newsroom

SCOPE Summit 2025: Peter Ronco on the Risks Small Biopharma Companies Face in Clinical Trial Partnerships

Go back to Newsroom

Go back to Newsroom

SCOPE Summit 2025: Peter Ronco Offers Tips to Small Biopharma Companies on Properly Scaling Clinical Programs

Go back to Newsroom